52 Years of Experience
Who is Dr. Rabinovitch, Pediatric Cardiologist in Palo Alto, CA?
Dr. Marlene Rabinovitch, MD is a Pediatric Cardiologist, who primarily practices in Palo Alto, CA. She has been practicing for over 52 years and is board certified. Dr. Rabinovitch graduated from McGill University Faculty of Medicine, completed her residency at University of Colorado Program A, and is currently affiliated with Packard Childrens Hospital At Stanford. Dr. Rabinovitch is fluent in English and French, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Rabinovitch’s office at (650) 497-8000.
Where did Dr. Rabinovitch go to medical school and complete their residency?
Residency: University of Colorado Program A
Medical School: McGill University Faculty of Medicine
Is Dr. Rabinovitch board certified as a Pediatric Cardiologist?
Yes, Dr. Marlene Rabinovitch, MD is board certified by the American Board of Pediatrics
What languages does Dr. Rabinovitch speak?
Dr. Rabinovitch and their clinical team can communicate with patients in the following languages:
English
French
What conditions does a Pediatric Cardiologist like Dr. Rabinovitch typically treat?
As a Pediatric Cardiologist, conditions treated by Dr. Marlene Rabinovitch may include:
- Arrhythmia
- Atherosclerosis
- Atrial Fibrillation
- Carotid Stenosis
- Coronary Heart Disease
- Endocarditis
- Heart Attack
- Heart Disease
Please contact Dr. Rabinovitch's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Pediatric Cardiologist like Dr. Rabinovitch typically perform?
As a Pediatric Cardiologist, procedures performed by Dr. Marlene Rabinovitch may include:
- Absent Pulmonary Valve Repair
- Anomalous Coronary Artery Angiography
- Anticoagulation Management
- Aortic Stenosis Repair
- Aortic Valve Repair / Replacement
- Aortopulmonary Window Repair
- Arterial Doppler
- Balloon Septostomy
Please contact Dr. Rabinovitch's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Rabinovitch accept my insurance?
Please contact Dr. Rabinovitch's office to confirm accepted insurance plans.
Where is Dr. Rabinovitch's office located?
Recognitions
Publications
Reduced BMPR2 expression induces GM
, 2014
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmory hypertension.
, 2013
Combining induced pluripotent stem cell with next generation sequencing technology to gain new
, 2013
Loss of adenomatous poliposis coli
, 2012
Neutrophil Elastase Is Produced by Pulmory Artery Smooth Muscle Cells
, 2011
Disruption of PPAR gamma
, 2011
Inhibition of Transforming Growth Factor beta Worsens Elastin Degradation
, 2011
BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt
, 2011
Tie2-mediated loss of peroxisome proliferator
, 2009
S100A4 and Bone Morphogenetic Protein
, 2009
Bone morphogenetic protein 2 induces pulmory angiogenesis via Wnt-beta-catenin
, 2009
SM22 alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac
, 2008
An antiproliferative BMP
, 2008
Relevant issues in the pathology and pathobiology of pulmory hypertension.
, 2013
Chronic effects of pulmory artery stenosis on hemodymic and structural development of the lungs
, 2013
Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmory Hypertension
, 2011
Inhibiting Lung Elastase Activity Ebles Lung Growth in Mechanically Ventilated Newborn Mice
, 2011
PPAR gamma and the Pathobiology of Pulmory Arterial Hypertension
, 2010
Prolonged mechanical ventilation with air induces apoptosis
, 2010
Cholinergic Modulation of Angiogenesis: Role of the 7 Nicotinic Acetylcholine Receptor
, 2009
LC3-mediated fibronectin mR translation induces fibrosarcoma growth by increasing connective tissue
, 2009
Balloon occlusion pulmory wedge angiography
, 2009
Insulin resistance in pulmory arterial hypertension
, 2009
VEGF blockade inhibits angiogenesis and reepithelialization of endometrium
, 2008
Molecular pathogenesis of pulmory arterial hypertension
, 2008
Pulmory arterial remodeling induced by a Th2 immune response
, 2008
Smooth muscle protein 22 alpha
, 2008
Reactivation of gamma HV68 induces neointimal lesions in pulmory arteries of S100A4
, 2008
Developmental expression of LC3 alpha and beta
, 2008
Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis
, 2008
Mechanical ventilation with 40% oxygen reduces pulmory expression of genes that regulate lung
, 2007
Point: Counterpoint: Chronic hypoxia-induced pulmory hypertension does
, 2007
Dysregulation of pulmory elastin synthesis and assembly in preterm lambs with chronic lung disease
, 2007
Nuclear factor-kappa B activation in neotal mouse lung protects against lipopolysaccharide
, 2007
Pulmory arterial hypertension is linked to insulin resistance
, 2007
Pathobiology of pulmory hypertension
, 2007
Cellular and molecular pathobiology of pulmory hypertension conference summary
, 2005
Mts1/S100A4 stimulates human pulmory artery
, 2005
Caspases from apoptotic myocytes degrade extracellular matrix: a novel remodeling paradigm.
, 2005
Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct
, 2005
Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmory hypertension
, 2005
Interdependent serotonin transporter and receptor pathways regulate S100A4
, 2005
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis
, 2005
Subversion of cellular autophagosomal machinery by R viruses
, 2005
Apolipoprotein D and platelet-derived growth factor
, 2004
Elafin-overexpressing mice have improved cardiac function after myocardial infarction
, 2004
Pulmory arterial hypertension - Future directions - Report of a tiol Heart
, 2004
Cellular and molecular pathobiology of pulmory arterial hypertension
, 2004
The mouse through the looking glass - A new door into the pathophysiology of pulmory hypertension
, 2004
S100A4/Mts1 produces murine pulmory
, 2004
S100A4/Mts1 produces murine pulmory
, 2004
Apolipoprotein D and PDGF-BB synergism mediates vascular smooth muscle cell migration.
, 2004
Apolipoprotein D inhibits platelet-derived growth factor
, 2003
Low molecular weight heparin
, 2003
Temporal response and localization of integrins beta 1 and beta 3
, 2003
Elafin overexpressing mice have improved cardiac function after myocardial infarction.
, 2003
Apolipoprotein D inhibits PDGF induced v
, 2003
Dexfenfluramine protects against pulmory hypertension in rats
, 2002
Understanding and treating vein graft atherosclerosis
, 2002
Pulmory arterial hypertension in congenital heart disease.
, 2002
Novel notions on newborn lung disease
, 2002
Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis
, 2002
Fetal pulmory artery diameters and their association with lung hypoplasia and posttal outcome
, 2002
Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic
, 2002
Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation
, 2001
Pathobiology of pulmory hypertension - Extracellular matrix
, 2001
Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor
, 2001
Tumor necrosis factor
, 2001
Conditiol and targeted overexpression of vascular chymase causes hypertension in transgenic mice
, 2001
A novel vascular smooth muscle chymase is upregulated in hypertensive rats
, 2001
Hemodymic unloading leads to regression of pulmory vascular disease in rats
, 2001
Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration.
, 2000
Isolated ductus arteriosus aneurysm in the fetus and infant: A multi-institutiol experience
, 2000
Complete reversal of fatal pulmory hypertension in rats by a serine elastase inhibitor
, 2000
Suppressed smooth muscle proliferation
, 2000
Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP
, 2000
Under new magement - A six-month progress report on Circulation Research
, 2000
Elastase and matrix metalloproteise inhibitors induce regression
, 2000
Pathobiology of pulmory hypertension: Impact on clinical magement.
, 2000
Adventitial fibroblasts - Defining a role in vessel wall remodeling
, 2000
Circulation research Editors' yearly report: 1999-2000
, 2000
Pulmory hypertension: Pathophysiology as a basis for clinical decision making
, 1999
Functiol and antigenic concentrations of alpha-1
, 1999
Nitric oxide mediates LC-3
, 1999
EVE and beyond, retro and prospective insights
, 1999
Survival of Mycobacterium avium
, 1999
Regression of hypertrophied rat pulmory arteries
, 1999
Targeted overexpression of elafin protects mice against cardiac dysfunction
, 1999
Induction of vascular smooth muscle cell tescin
, 1999
Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting
, 1999
A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function
, 1998
Tissue-specific and developmental regulation of transforming growth factor-beta
, 1998
Microtubule involvement in translatiol regulation of fibronectin expression by light chain 3 of
, 1998
Elastase and the pathobiology of unexplained pulmory hypertension
, 1998
AML1-like transcription factor induces serine elastase activity in ovine pulmory artery smooth
, 1998
Mechanisms of proliferative and obliterative vascular diseases
, 1998
Endothelial and serum factors which include apolipoprotein A1 tether elastin to smooth muscle cells
, 1998
Microtubule-associated protein 1 light chain 3 is a fibronectin mR
, 1997
Regulation of tescin-C
, 1997
New insights and therapeutic strategies for postcardiac transplantation corory artery disease
, 1997
Pulmory hypertension: Updating a mysterious disease
, 1997
Tescin-C, proliferation and subendothelial fibronectin in progressive pulmory vascular disease
, 1997
The committed vascular smooth muscle cell: A question of 'timing' or 'response to pressure' or both
, 1997
Carbon monoxide formation in the ductus arteriosus in the lamb
, 1997
Cell-extracellular matrix interactions in the ductus arteriosus and perital pulmory circulation
, 1996
Tescin-C is induced with progressive pulmory vascular disease in rats
, 1996
Gerbode's defect associated with acute sinus node dysfunction as a complication of infective
, 1996
It all begins with eve (endogenous vascular elastase)
, 1996
Fusion of Leishmania amazonensis par
, 1996
Elafin, a serine elastase inhibitor
, 1996
Functiol interplay between interleukin-1 receptor
, 1996
Cohabitation of Leishmania amazonensis and Coxiella burnetii
, 1996
Exogenous leukocyte
, 1996
Elastase and cell matrix interactions in the pathobiology of vascular disease.
, 1995
INCREASED ELASTIN-DEGRADING ACTIVITY AND NEOINTIMAL FORMATION IN PORCINE AORTIC ORGAN
, 1995
Cytokine-mediated fibronectin production
, 1995
EXPERIENCE WITH REPAIR OF CONGENITAL HEART-DEFECTS USING ADJUNCTIVE ENDOVASCULAR DEVICES
, 1995
INCREASED RESPIRATORY SYSTEM RESISTANCE AND BRONCHIAL SMOOTH
, 1995
LYMPHOCYTE TRANSENDOTHELIAL MIGRATION TOWARD SMOOTH-MUSCLE CELLS IN INTERLEUKIN
, 1995
ABNORMALITIES IN INTRAMYOCARDIAL ARTERIES DETECTED IN CARDIAC TRANSPLANT BIOPSY SPECIMENS
What is Dr. Rabinovitch's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Rabinovitch's National Provider Identifier (NPI) number is 1861414906.
What common questions do patients ask about Dr. Rabinovitch?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Rabinovitch
What is Dr. Marlene Rabinovitch's specialty?
Dr. Rabinovitch is a Pediatric Cardiologist near Palo Alto, CA.
What does a Pediatric Cardiologist do?
A pediatric cardiologist provides comprehensive care for children with cardiovascular issues, offering expertise in diagnosing, treating, and managing heart and blood vessel conditions. This specialist is skilled in selecting, performing, and interpreting structural and functional assessments of the heart and blood vessels, as well as conducting thorough clinical evaluations of cardiovascular diseases in young patients.
Is this Dr. Marlene Rabinovitch affiliated with a ranked Castle Connolly Top Hospital?
No, Rabinovitch is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Stanford Medicine Children’s Health. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Pediatric Cardiologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Pediatric Cardiologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Marlene Rabinovitch accepting new patients in Palo Alto, CA?
Yes, Dr. Marlene Rabinovitch is accepting new patients at this time.
Does Dr. Marlene Rabinovitch offer online booking?
Please contact Dr. Rabinovitch's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Marlene Rabinovitch?
Please contact Dr. Rabinovitch's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Marlene Rabinovitch have?
Dr. Marlene Rabinovitch is certified by the American Board of Pediatrics.
Other Pediatric Cardiologist Near Palo Alto, CA
Pediatric Cardiologist
Accepting patientsPediatric Cardiologist
Accepting patientsPediatric Cardiologist
Accepting patientsConnect with DR. Rabinovitch
Packard Childrens Hospital At Stanford
725 Welch Rd
Palo Alto, CA 94304